A
positron emission tomography (PET) - computed tomography (CT) scan
reveals information about both the structure and function of cells
and tissues in the body during a single imaging session. In recent
times, majority of PET scans are performed on instruments that are
combined with PET and CT scanners. The combined PET-CT scans provide
images that identify the anatomic location of abnormal metabolic
activity within the body. The combined scans have been shown to
provide more accurate diagnoses than the two scans performed
separately.
The
diagnosis of various diseases such as cancer, heart diseases, and
certain brain disorders require the use of both PET and CT scans. PET
scanners measure metabolic activity, whereas CT scanners highlight
anatomical features. The risk to poor superimposition of separate
imaging is reduced and the hybrid PET-CT process lessens burden on
the patient by simplifying the scanning process. The use of PET-CT
scanner hybrids combine the strengths of two well-established imaging
modalities and helps in accurate diagnosis, localizing, and
monitoring of the disease. Moreover, PET-CT scanners can record the
images in extremely short time (less than a minute).
Request
Free Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2169
The
global PET-CT scanner device market size was valued at US$ 1.9
billion in 2017 and is expected to witness a CAGR of 5.1% over the
forecast period (2018 – 2026).
Increasing
prevalence of chronic diseases and rising geriatric population is
expected to drive the PET-CT scanner device market revenue
Rising
prevalence of infectious and chronic diseases such as cancer and
heart disease across the globe and increasing demand for effective
diagnostic systems is expected to drive the PET-CT scanner market
size. According to the National Centre for Health Statistics, 2011,
heart disease is the leading cause of death in the U.S., killing over
600,000 people each year.
According
to the International Agency for Research on Cancer (IARC), in 2012,
an estimated 14.1 million new cancer cases were reported, globally.
Among these, the most common form of cancer was lung cancer (13%),
breast cancer (11.9%), and colorectal cancer (9.7%). According to the
Centers for Disease Control and Prevention (CDC), February 2018 data,
around 22,000 men and 9,000 women suffer from liver cancer, and
around 16,000 men and 8,000 women die due to liver cancer, every year
in the U.S.
PET-CT
Scanner Device Market - Regional Insights
On
the basis of region, the global PET-CT scanner device market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa. North America is expected to hold dominant
position in the global PET-CT scanner device market, owing to rising
number of traumatic brain injury cases in the U.S. For instance,
according to the Centers for Disease Control and Prevention (CDC), in
2013, around 282,000 people were diagnosed with brain injury and
around 50,000 people died due to traumatic brain injury in the U.S.
It is estimated to be a major cause of disability and death in the
U.S.
Get
Full Access of This Business Report @
https://www.coherentmarketinsights.com/market-insight/pet-ct-scanner-device-market-2169
PET-CT
Scanner Device Market - Competitive Landscape
Key
players operating in the global PET-CT scanner device market include
General Electric Co., Hitachi, Ltd., Mediso Ltd., Koninklijke Philips
N.V., PerkinElmer, Inc., Positron Corporation, Siemens AG, Shimadzu
Corporation, Toshiba Corporation, and Yangzhou Kindsway Biotech Co.
Ltd. Manufacturers are continually bringing in new PET/CT design. New
technology enables more precise measurements of metabolic processes
and data quantification, including assessment of cancerous tissue,
neurologic disease, and cardiac blood flow (perfusion).
Detailed
Segmentation:
Global
PET-CT Scanner Device Market, By Detector Type:
-
FluroDeoxyGlucose (FDG)
-
62CU ATSM
-
FMISO
-
Gallium
-
Thallium
-
Others
Global
PET-CT Scanner Device Market, By Setting:
-
Fixed
-
Mobile
Global
PET-CT Scanner Device Market, By Application:
-
Cardiology
-
Oncology
-
Neurology
-
Others
Purchase
Report Here:
https://www.coherentmarketinsights.com/insight/buy-now/2169
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment